FDA Inspection 1201265 — Nippon Sanso Matheson, Inc.
The FDA completed an inspection of Nippon Sanso Matheson, Inc. on Mar 2, 2023 in Albuquerque, NM. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 2, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Albuquerque, NM (United States)